←back to thread

Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)

(www.cnbc.com)
249 points randycupertino | 2 comments | 16 Nov 25 23:01 UTC | HN request time: 0.001s | source
Show context
egypturnash ◴[16 Nov 25 23:38 UTC] No.45949501[source]▶
Meanwhile over in the world where the government sinks a lot of money and energy into its citizen's healthcare, government-funded labs are exploring permanent cures for all kinds of problems via genetic therapy.

But not here. Someone's gotta make mad bank off of every aspect of this shit here.

replies(2): >>45949538 #>>45950042 #
loeg ◴[17 Nov 25 01:16 UTC] No.45950042[source]▶
Which governments in particular; how much funding; and what outcomes have they actually achieved?

(In general the US actually subsidizes pharma for the rest of the world.)

replies(1): >>45950625 #
1. Loughla ◴[17 Nov 25 03:29 UTC] No.45950625[source]▶
>In general the US actually subsidizes pharma for the rest of the world.

I've never understood this argument. Our companies make money off of people in other countries. I understand that our costs are higher in the US, but I don't get how we're subsidizing the rest of the world when they pay for the drugs as well. It just seems like our funding scheme for healthcare is broken. What am I missing?

replies(1): >>45958937 #
2. loeg ◴[17 Nov 25 22:09 UTC] No.45958937[source]▶
https://reason.org/commentary/how-america-subsidizes-medicin...